A co-founder of Haverford Healthcare Advisors in 1994, Christopher has over 30 years of transaction advisory and business valuation experience. During his career, he has worked on numerous business valuation and transaction advisory engagements involving over 1,400 business entities in the healthcare services industry. He has originated and completed transactions with a combined value in excess of $2.5 billion.
In 2006, Mr. Jahnle co-founded Aurora Diagnostics, LLC (www.AuroraDx.com), a national anatomic pathology laboratory company headquartered in Palm Beach Gardens, Florida. Today, Aurora Diagnostics employs over 1,000 individuals, including over 100 pathologists, and has annual net revenue approximating $250 million. From 2006 through 2014, Haverford initiated and completed 26 acquisitions of pathology practices and laboratories on behalf of Aurora Diagnostics as its exclusive acquisition advisor.
Christopher holds a BS in Commerce and Engineering Sciences and an MS in Taxation from Drexel University. His education has been supplemented by numerous continuing professional education courses, including many specific to the healthcare industry.
Professional Certifications & Affiliations
Since 1989, Christopher has been an Accredited Senior Appraiser (“ASA”) and Member of the American Society of Appraisers, where he is designated in the specialty of business valuation. He is also a member of the CFA Society of Philadelphia; the CFA Institute; the Clinical Laboratory Management Association; the Medical Group Management Association, and the Radiology Business Management Association.
Christopher speaks regularly at healthcare industry conferences on valuation issues, mergers and acquisitions, and industry trends. He has published numerous articles in healthcare publications and has written industry reports that have been circulated to thousands of business owners.